MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0061607
Orex Pharma Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹49.78 Cr
▲ 16% YoY
Net profit · FY 2025
₹3.09 Cr
Net margin 6.2%
EBITDA · FY 2025
₹6.66 Cr
EBITDA margin 13.4%
Authorised capital
₹3.1 Cr
Registered with MCA
Paid-up capital
₹2.29 Cr
Issued & subscribed
Open charges
₹47.49 Cr
Secured borrowings
Company age
47 yrs
Est. 1979
Employees · EPFO
138
Provident fund records
About Orex Pharma Private Limited
Data last updated:
Orex Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 20 June 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1979PTC021403. Its GSTIN is 27AAACO0984E1ZJ (Maharashtra).
The company has an authorised share capital of ₹3.1 Cr and a paid-up capital of ₹2.29 Cr. It is led by directors including Baburao Krishnaji Pisal (Managing Director) and Mangesh Baburao Pisal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pisal House Nakhwa Compound Stadium Road Thane (W), Maharashtra, India – 400601.
As per the financials filed for FY 2025, the company reported a revenue of ₹49.78 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹3.09 Cr (net margin 6.2%) and EBITDA of ₹6.66 Cr (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 10% over five years.
The company has about 138 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Orex Pharma. As per MCA filings, the company has open charges of ₹47.49 Cr on record. Court records list 14 cases involving the company, including 11 filed by the company and 3 filed against it.
Orex Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0061607). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orexpharma.com.
Company details
CIN U99999MH1979PTC021403
Registration Number 021403
Incorporation Date 20 June 1979
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0061607
Key People
Baburao Krishnaji Pisal Managing Director Mangesh Baburao Pisal Director Kiran Baburao Pisal Director Recognitions & Rankings of Orex Pharma
Contact details
Orex Pharma Private Limited's registered office is in Thane, Maharashtra. Its website is orexpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPisal House Nakhwa Compound Stadium Road Thane (W), Maharashtra, India – 400601
- IndustryPharma, Animal Pharmaceuticals & Healthcare, API Manufacturers
To see the full contact details of Orex Pharma Private Limited, buy the company report.
Comprehensive company report
Orex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Orex Pharma operates one associated brand: Orex Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| API manufacturing and supply in the pharmaceutical sector are undertaken by OREX Pharma. | orexpharma.com |
Business activity
The main business activity of Orex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Orex Pharma Private Limited, buy the company report.
Financials of Orex Pharma Private Limited
FY 2025 filings availableOrex Pharma Private Limited reported revenue of ₹49.78 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹49.78 Cr ▲ 16%
Net profit · FY 2025
₹3.09 Cr margin 6.2%
EBITDA · FY 2025
₹6.66 Cr margin 13.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 8%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 8%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 16% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹49.78 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orex Pharma Private Limited, buy the company report.
Board of directors of Orex Pharma Private Limited
Orex Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Baburao Krishnaji Pisal Also directs: Orex Pharma Exports LLP | Managing Director | 20 Jun 1979 | 47 Years 4 Months | Current |
| Mangesh Baburao Pisal Also directs: Trezure Casa LLP, Modaform Living Private Limited | Director | 01 Oct 2004 | 22 Years 0 Months | Current |
| Kiran Baburao Pisal | Director | 01 Oct 2010 | 16 Years 0 Months | Current |
Peer comparison
Orex Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orex Pharma Private Limitedthis company | ₹49.78 Cr (FY 2025) | ₹3.09 Cr | 6.2% | 16.0% | 138 | Thane, Maharashtra, India |
| Panvo Organics Private Limited | ₹44.09 Cr (FY 2024) | 0.0% | Chennai, Tamil Nadu, India | |||
| Shalini Organics Private Limited | ₹43.48 Cr (FY 2024) | 103.0% | Aurangabad, Maharashtra, India | |||
| Orchev Pharma Pvt Ltd | ₹43.44 Cr (FY 2025) | 14.0% | Rajkot, Gujarat, India | |||
| Basil Drugs and Pharmaceuticals Private Limited | ₹42.89 Cr (FY 2025) | 73.0% | Mumbai, Maharashtra, India | |||
| Basic Pharma Life Science Private Limited | ₹42.57 Cr (FY 2024) | -24.0% | Bharuch, Gujarat, India | |||
| Allastir Private Limited | ₹42.05 Cr (FY 2024) | -3.0% | Chennai, Tamil Nadu, India | |||
| Keshar Emulsion Private Limited | ₹41.86 Cr (FY 2024) | -23.0% | Ahmedabad, Gujarat, India | |||
| Hi Tech Biosciences India Private Limited | ₹41.75 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India |
To see the full peer comparison of Orex Pharma Private Limited, buy the company report.
Auditor
Orex Pharma Private Limited is audited by SUMARIA & SUMARIA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUMARIA & SUMARIA | FY 2024 | 124343W |
Shareholding
The shareholding of Orex Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Orex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹47.49 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jan 2026 | 101262331 | Hdfc Bank Limited | ₹15 Lakh | Open | |
| 21 Nov 2025 | 101197412 | Hdfc Bank Limited | ₹15.38 Lakh | Open | |
| 16 Jun 2025 | 101124604 | Others | ₹25 Lakh | Open | |
| 31 Jan 2024 | 100864811 | Others | ₹2 Cr | Open | |
| 10 Oct 2022 | 100622406 | Others | ₹11 Cr | Open |
To see the full charge records of Orex Pharma Private Limited, buy the company report.
Total charge records: 25 View all charges
Legal cases
Orex Pharma Private Limited has 14 court cases on record: 11 filed by Orex Pharma, 3 filed against it. All cases are disposed.
Total cases
14
Filed by the company
11
Filed against the company
3
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 2 | 0 |
| High courts | 5 | 1 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COARP) | Filed by the company against Oriental Insurance Co.Ltd | Disposed |
| Bombay High Court | Company petition | Filed against the company by Kotak Mahindra Bank Ltd. Through Its Manager Sanjay Gurav | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against Ms.Rane Drugs Pvt.Ltd. 1 | Disposed |
| High Court, MAHARASHTRA | Court case (COARP) | Filed by the company against Oriental Insurance Co Ltd | Disposed |
| Bombay High Court | Court case (ARP) | Filed by the company against Oriental Insurance Co.Limited | Disposed |
To see the full case history of Orex Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Orex Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 14 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mentor Pharma (Creditor) | |||
| Mody Chemi Pharma Limited | |||
| Sima Products | |||
| an individual supplier | |||
| Sahil Pharma Chemicals Private Limited |
To see the full MSME payment records of Orex Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Orex Pharma Private Limited has a workforce of 138 employees on its EPFO records as of Mar 04, 2025, across 10 active EPFO establishments.
Employee count
138
Active EPFO establishments
10
Employee growth
5.34%
GST
Orex Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACO0984E1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Orex Pharma Private Limited, buy the company report.
Recent activity
Orex Pharma Private Limited has 5 board changes on record since 1979: 3 appointments and 2 cessations. The latest: Suman Baburao Pisal ceased to be Director on 15 Jun 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101262331 was registered on 16 Jan 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101197412 was registered on 21 Nov 2025.
AGM
Orex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 11.00 Cr registered on 10 Oct 2022 with Charge ID 100622406 was modified on 22 Sep 2025.
Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 101124604 was registered on 16 Jun 2025.
Filing
Orex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others of Rs. 2.00 Cr registered on 31 Jan 2024 with Charge ID 100864811 was modified on 21 Mar 2024.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100864811 was registered on 31 Jan 2024.
Charges
A charge with Others of Rs. 6.24 Cr registered on 10 Oct 2022 with Charge ID 100622407 was modified on 13 Dec 2022.
Charges
A charge with Others of Rs. 0.75 Cr registered on 10 Oct 2022 with Charge ID 100622409 was modified on 13 Dec 2022.
Charges
A charge with Others amounted to Rs. 6.24 Cr with Charge ID 100622407 was registered on 10 Oct 2022.
Charges
A charge with Others amounted to Rs. 0.75 Cr with Charge ID 100622409 was registered on 10 Oct 2022.
29 earlier events are in the company report.
Frequently asked questions
Orex Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 20 June 1979 (47+ years old) and is registered under CIN U99999MH1979PTC021403.
Orex Pharma has 3 current directors:
- Baburao Krishnaji Pisal - Managing Director
- Mangesh Baburao Pisal - Director
- Kiran Baburao Pisal - Director
The latest financial statements of Orex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Orex Pharma is 27AAACO0984E1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Orex Pharma is U99999MH1979PTC021403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orex Pharma has 14 court cases on record: 11 filed by the company and 3 filed against it. Most are in the district courts.
Orex Pharma was incorporated on 20 June 1979, making it 47+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Orex Pharma by revenue are Panvo Organics Private Limited, Shalini Organics Private Limited, Orchev Pharma Pvt Ltd, Basil Drugs and Pharmaceuticals Private Limited, Basic Pharma Life Science Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suman Baburao Pisal ceased to be Director on 15 Jun 2018. Kiran Baburao Pisal ceased to be Additional Director on 30 Sep 2011. Kiran Baburao Pisal was appointed as Director on 01 Oct 2010. Orex Pharma has 5 board changes on record in total.
Yes, Orex Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0061607).
Orex Pharma has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 14 overdue payments to 12 micro and small suppliers. The latest return was filed on 09 Jun 2019.
Orex Pharma can be reached through the website orexpharma.com. Its registered office is in Thane, Maharashtra, India.